rocuronium kabi 10 mg/ml
fresenius kabi austria gmbh - austria - bromurĂ de rocuronium - sol. inj./perf. - 10mg/ml - miorelaxante periferice derivati cuaternari de amoniu
rocuroniu kalceks 10 mg/ml soluţie injectabilă/perfuzabilă
kalceks sa - rocuronii bromidum - soluţie injectabilă/perfuzabilă - 10 mg/ml
rocuronium aguettant 10 mg/ml
laboratoire aguettant - franta - bromurĂ de rocuronium - sol inj. in seringa preumpluta - 10mg/ml - miorelaxante periferice derivati cuaternari de amoniu
esmeron 10 mg/ml soluţie injectabilă
schering-plough central east ag - rocuronii bromidum - soluţie injectabilă - 10 mg/ml
esmeron 10 mg/ml soluţie injectabilă
schering-plough central east ag - rocuronii bromidum - soluţie injectabilă - 10 mg/ml
esmeron 10 mg/ml soluţie injectabilă
merck sharp & dohme romania s.r.l. - rocuronii bromidum - soluţie injectabilă - 10 mg/ml
esmeron 10 mg/ml
n.v. organon - olanda - bromurĂ de rocuronium - sol. inj. - 10mg/ml - miorelaxante periferice derivati cuaternari de amoniu
bridion
merck sharp & dohme b.v. - sugammadex - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. pentru populația pediatrică: sugammadex este recomandat numai pentru reversia de rutină de rocuronium-a indus blocada la copii și adolescenți.
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.